Recent Advances in the Use of NK Cells Against Cancer

Feb 18, 2017 by in ONCOLOGY Comments Off on Recent Advances in the Use of NK Cells Against Cancer

© Springer-Verlag Berlin Heidelberg 2015Nima Rezaei (ed.)Cancer Immunology10.1007/978-3-662-44946-2_18 18. Recent Advances in the Use of NK Cells Against Cancer Amy E. Gillgrass1  , Tamara Krneta1   and Ali A. Ashkar1   (1) Department of Pathology and Molecular Medicine, McMaster Immunology Research Center…

read more

Gene Therapy and Virus-Based Cancer Vaccines

Feb 18, 2017 by in ONCOLOGY Comments Off on Gene Therapy and Virus-Based Cancer Vaccines

  Gammaretrovirus vectors Lentivirus vectors Adenovirus vectors Adeno-associated virus vectors Herpes simplex virus-1 vectors Cloning capacity 7–7.5 kb 18 kb 37 Kb 4.9 kb Up to 152 kb (dependent on…

read more

Immunologic Approaches to Targeting Cancer Stem Cells

Feb 18, 2017 by in ONCOLOGY Comments Off on Immunologic Approaches to Targeting Cancer Stem Cells

Tumor type Markers Reference Bladder ABCG2high SP (side population, Hoechst dye) [12] ALDH1high [13] Breast CD44+CD24−/low [10] ALDH1high [14] Colon CD133+ [15] EpCAMhigh CD44+ [16] ALDH1high [17] Gastric CD44+ [18]…

read more

Overcoming Cancer Tolerance with Immune Checkpoint Blockade

Feb 18, 2017 by in ONCOLOGY Comments Off on Overcoming Cancer Tolerance with Immune Checkpoint Blockade

Fig. 6.1 Multiple immunomodulatory coinhibitory and costimulatory receptor-ligand pairs have been identified (although not all are depicted here). These pathways set the immunologic context when an antigen is presented on…

read more

Strategies to Target Tumor Immunosuppression

Feb 18, 2017 by in ONCOLOGY Comments Off on Strategies to Target Tumor Immunosuppression

Type of therapy Targeted pathway Achieved effect Local tumor irradiation Antigen presentation and processing Enhanced intratumor homing of effector CTLs Release of TAAs Production of inflammatory cytokines Endothelin receptor blockade…

read more
Get Clinical Tree app for offline access